Qualigen Therapeutics, Inc. logo

QLGNQualigen Therapeutics, Inc.

QLGN Stock Price, Valuation & Chart | Qualigen Therapeutics, Inc.

Compare

QLGN Historical price chart

QLGN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization5.43M
PE Ratio1.13
EPS2.85
Trading Volume368.77K
Today's High/Low3.34/2.86
Dividend Yield0.00
52 Week High/Low8.81/1.61
Shares Outstanding1.69M
QLGN Financial Statement
QLGN Analyst ratings
QLGN Analysis & performance metrics

QLGN Company profile

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid…

QLGN Management team

Management
Michael S. PoirierCOO
Chief Operating Officer
Kevin A. Richardson IICEO
Interim Chief Executive Officer, Interim Chief Financial Officer & Chairman of the Board
Robert W. Campbell BecherCTO
President & Director
Christopher L. Lotz
Vice President of Finance & Corporate Secretary
Total 4 executives

QLGN Frequently asked questions

What is Qualigen Therapeutics, Inc. (QLGN) Stock Price?

Current stock price of Qualigen Therapeutics, Inc. (QLGN) stock is $3.210. The stock price is +5.59% higher in the session. The intraday range can be seen from this page. Volume of Qualigen Therapeutics, Inc. (QLGN) stock is 368.77K.

Last updated at 18 Nov 2025, 09:00 pm.

Why is the Qualigen Therapeutics, Inc. (QLGN) stock price going up or down today?

The stock price of Qualigen Therapeutics, Inc. (QLGN) can change with earnings, company news, and overall market sentiment. Qualigen Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Qualigen Therapeutics, Inc. stock expensive at its current price?

Whether Qualigen Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for QLGN on this page is 1.13. EPS on this page is 2.85. Compare those figures with peers and growth expectations before deciding if the current Qualigen Therapeutics, Inc. price is justified.

How has the stock price of Qualigen Therapeutics, Inc. (QLGN) performed historically?

Historical performance for Qualigen Therapeutics, Inc. (QLGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how QLGN reacted to past earnings and market events.

Should I buy Qualigen Therapeutics, Inc. (QLGN) stock, at this price?

Buying Qualigen Therapeutics, Inc. (QLGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.